79397843 - A3P

Information

  • Trademark
  • 79397843
  • Serial Number
    79397843
  • Filing Date
    March 21, 2024
    a year ago
  • Transaction Date
    July 26, 2025
    11 days ago
  • Status Date
    July 25, 2025
    12 days ago
  • Location Date
    July 25, 2025
    12 days ago
  • Status Code
    680
  • Current Location
    TMO LAW OFFICE 112
    Employee Name
    SINGER, MELANIE
  • Attorney Docket Number
    TM-12008
    Attorney Name
    Ronald E. Shapiro
    Law Office Assigned Location Code
    M30
  • Owners
Mark Drawing Code
4
Mark Identification
A3P
Case File Statements
  • GS0091: Downloadable software for calculating the risk of prostate cancer; downloadable computer programs for calculating the risk of prostate cancer; downloadable computer software for prostate cancer tests; downloadable application software for calculating the risk of prostate cancer; scientific research and laboratory apparatus for measuring proteins and genetics; educational apparatus and simulators, namely, medical diagnostics training simulators in the field of prostate cancer; scientific laboratory research instruments for the detection of proteins and genetics for medical research and training purposes; and parts and fittings for all the aforesaid goods included in this class, namely, computer peripherals and parts thereof
  • GS0051: Medical and veterinary preparations and articles, namely, diagnostic test reagents for medical purposes for prostate cancer testing; diagnostic preparations and material preparations in the nature of pharmaceuticals for medical purposes being for treatment of cancer; reagents for use in diagnostic tests for medical purposes; diagnostic testing materials for medical use in the nature of reagents for medical purposes; diagnostic test materials reagents for medical purposes for prostate cancer testing; diagnostic preparations for medical purposes; diagnostic agents for medical use
  • PM0001: A THREE P
  • GS0441: Human healthcare services, namely, disease management programs; medical services; medical testing services; medical diagnostic services; medical diagnostic testing services for prostate cancer; providing online information services relating to medical and diagnostic tests, namely information regarding prostate cancer tests for diagnosis and treatment purposes; prostate cancer screening services; prostate cancer medical testing services; prostate cancer diagnostic medical testing services; medical testing services relating to prostate cancer; taking of blood for medical testing in the nature of phlebotomy services; services for the medical testing of blood; performing diagnosis of diseases; medical testing for diagnostic or treatment purposes; medical diagnostic services, namely, blood sampling and analysis; medical services for the diagnosis of conditions of the human body; medical analysis for the diagnosis and treatment of persons; medical testing services relating to the diagnosis and treatment of disease in the nature of medical diagnostic services; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; providing medical information relating to medical results and diagnostic tests, namely, prostate cancer tests; providing medical diagnostic information relating to medical test results; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory analysis services for the analysis of samples and blood samples taken from patients for diagnostic and treatment purposes; rental of medical equipment for human healthcare; and advice, consultancy, and information relating to the aforesaid, included in this class, namely, medical diagnostic consulting and information services
  • GS0101: Medical and veterinary apparatus and instruments, namely, protein and genetics measurements instruments for diagnostic and treatment purposes; medical diagnostic, examination, and monitoring equipment for prostate cancer for medical treatment purposes; testing apparatus for medical purposes for prostate cancer detection; medical test instruments for diagnosis and treatment of prostate cancer; testing probes for medical diagnostic purposes; testing instruments for medical diagnostic purposes being for use in diagnosing prostate cancer; tools for medical diagnosis of prostate cancer, namely, tools for calculation of prostate cancer risk; apparatus for carrying-out diagnostic tests for medical purposes, namely, ultrasound diagnostic apparatus for diagnosing prostate cancer
  • GS0421: IT integration services; computer software development, programming and implementation for others; website hosting services; software as a service featuring computer software for calculating a prostate cancer risk score; rental of computer software for calculating cancer risk; providing temporary use of online non¬-downloadable computer software for calculating a prostate cancer risk score; application service provider, featuring computer software programs for calculating a prostate cancer risk score; scientific and technology services, namely, scientific research, analysis, and testing, and medical and pharmacological research services in the field of prostate cancer; conducting research clinical trials for others in the field of prostate cancer; scientific research for medical purposes in the area of cancerous diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on clinical studies via an interactive website; medical research laboratory services in the field of prostate cancer; and advice, consultancy and information relating to the aforesaid, included in this class, namely, medical research laboratory services
Case File Event Statements
  • 6/20/2024 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 6/21/2024 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/21/2024 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/29/2024 - 10 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/29/2024 - 10 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/30/2024 - 10 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/7/2024 - 10 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/7/2024 - 10 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 10/26/2024 - 9 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/6/2024 - 9 months ago
    10 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/28/2025 - 4 months ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/28/2025 - 4 months ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/28/2025 - 4 months ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/13/2025 - 2 months ago
    14 - FINAL REFUSAL WRITTEN Type: CNFR
  • 5/13/2025 - 2 months ago
    16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 5/13/2025 - 2 months ago
    15 - FINAL REFUSAL E-MAILED Type: GNFR
  • 7/25/2025 - 12 days ago
    19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/25/2025 - 12 days ago
    17 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/25/2025 - 12 days ago
    18 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/25/2025 - 12 days ago
    20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/25/2025 - 12 days ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA